Outcomes in Adult Acute Promyelocytic Leukemia: A Decade Experience

Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

Francesco Lo‐Coco, Giuseppe Avvisati, Marco Vignetti et al. · New England Journal of Medicine · 2013 · 1.6K citations · Full text

Medicine, Hematology, Oncology +17

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Pierre Fenaux, Claude Chastang, Sylvie Chevret et al. · Blood · 1999 · 745 citations

Medicine, Hematology, Oncology +12

Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

Miguel Á. Sanz, Giuseppe Avvisati, Consuelo Rayón et al. · PubMed · 2000 · 632 citations

Medicine, Oncology, Pharmacology +17

Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.

Franco Mandelli, Daniela Diverio, Giuseppe Avvisati et al. · PubMed · 1997 · 474 citations

Medicine, Oncology, Pharmacology +10

A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.

Miguel Á. Sanz, Consuelo Rayón, Jordi Esteve et al. · PubMed · 1999 · 410 citations

Medicine, Oncology, Pharmacology +15